Silver Book reference

Changing the Trajectory of Alzheimer’s Disease: How a treatment by 2025 saves lives and dollars

45 Matching Facts

Search matching Facts:
No results to display
    • An Alzheimer’s disease treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce Medicaid costs for people with the disease by $14 billion in 2020–from…  
    • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the total costs of care for people with the disease by…  
    • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease in 2050 by…  
    • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease by $20 billion…  
    • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the costs of care for all people with the disease by…  
    • A treatment breakthrough that slowed the progression of Alzheimer’s disease would reduce the number of people with the disease from 2.4 million to 1.1 million in 2020, and from 6.5…  
    • Impact of Slowed Progression on Severe Stage, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
    • The federal share of Medicaid costs for nursing home care of Alzheimer’s disease residents will be $17 billion in 2010 and $85 billion in 2050.  The state share will be…  
    • Medicaid Nursing Home Costs, Delayed Onset  
    • Around half of all nursing home residents rely on Medicaid to help pay for their care.  In 2010, Medicaid costs for the nursing home care of Alzheimer’s patients will be…  
    • An Alzheimer’s treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce out-of-pocket costs to people with the disease by $25 billion in 2050–from the…  
    • An Alzheimer’s treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce out-of-pocket costs to people with the disease by $8 billion in 2020–from the…  
    • An Alzheimer’s treatment breakthrough that slowed disease progression and began to show effects in 2015, would reduce Medicaid costs for people with the disease by $62 billion–from the expected $178…  
    • Out-of-Pocket Costs, Slowed Progression  
    • Medicaid Costs, Slowed Progression  
    • Medicare Costs, Slowed Progression  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 out-of-pocket costs for individuals and families dealing with the…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 out-of-pocket costs to individuals and families dealing with the…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 Medicaid costs for people with the disease would be…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 Medicare costs for people with the disease would be…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 Medicare costs for people with the disease would be…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years were introduced in 2015, by 2050 the total reduction in cost of care for people…  
    • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 total cost of care (for all payers) for all people…  
    • A treatment that delayed the age of onset of Alzheimer’s disease by five years would reduce the proportion of Americans age 65 and older with the disease from 10% to…  
    • Impact of Slowed Progression by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050  
    • Impact of Slowed Progression on Alzheimer’s Disease Growth, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
    • Out-of-Pocket Costs, 5-Year Delayed Onset  
    • Medicaid Costs, 5-Year Delayed Onset  
    • Medicare Costs, 5-Year Delayed Onset  
    • Impact of a 5-Year Delay in Onset on Costs, Americans Age 65 and Older with Alzhemier’s Disease, 2010-2050  
    • Impact of a 5-Year Delay in Onset by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050  
    • Americans Age 65 and Older with Alzheimer’s Disease, 2010–2050  
    • “A treatment breakthrough that delayed the age of onset of Alzheimer’s disease by five years and began to show its effects in 2015 would decrease the total number of Americans…  
    • The costs to other payers (beyond Medicare, Medicaid, and out-of-pocket) will increase more than 400% between 2010 and 2050–from $22 billion to $117 billion.  
    • The out-of-pocket costs to people with Alzheimer’s disease will increase more than 400% between 2010 and 2050–from $30 billion to $157 billion.  
    • Medicaid costs for people with Alzheimer’s will increase 400% between 2010 and 2050–from $34 billion to $178 billion.  
    • Medicare costs for people with Alzheimer’s will increase more than 600% between 2010 and 2050–from $88 billion to $627 billion.  
    • Costs of Care for Americans Age 65 and Older with Alzheimer’s Disease and Other Dementias, 2010–2050  
    • Proportion of Americans Age 65 and Older with Alzheimer’s Disease by Stage of Disease, 2010–2050  
    • Between 2010 and 2050, the proportion of people with Alzheimer’s disese age 65 and older who are in the severe stage of the disease, will increase from 41 to 48%.   
    • By 2050, around 16% of Americans age 65 and older are projected to have Alzheimer’s disease.  
    • Number of Americans Age 65 and Older with Alzheimer’s Disease, 2010 – 2050  
    • In 2009, around 11 million Americans provided 12.5 billion hours of unpaid care for people with Alzheimer’s disease and other dementias.  
    • Between 2010 and 2050, the total costs of caring for Americans with Alzheimer’s disease–age 65 and older–will increase 5-fold–from $172 billion to $1.08 trillion each year.  These figures include the…  
    • Cost of Care for People with Alzheimer’s Disease